Biocytogen Enters into Antibody Agreement with Merck
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING, April 29, 2022 /PRNewswire-AsiaNet/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen's proprietary antibodies against at least three distin...
Authors: LATEST ASIANET NEWS RELEASES